Search

everythinglearnresearchcommunity

for

Search:↓

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

New FUE systems have greatly improved hair restoration surgery.

A reliable method was created to measure dutasteride and related molecules in capsules.

Tissue-engineered skin substitutes can model junctional epidermolysis bullosa and may help develop gene therapy.

The DNS FUE technique offers discreet hair transplants with high satisfaction and low damage rates.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

Deep phenotyping helps distinguish between xeroderma pigmentosum and trichothiodystrophy, aiding in diagnosis and treatment.

TAK-279 effectively reduces psoriasis symptoms and is safe.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

DHA derivatives, especially didocosahexaenoin, effectively kill prostate cancer cells and may offer a safer cancer treatment option.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

CD8+ T cells re-expressing CD45RA may predict treatment resistance in severe alopecia areata.

DPC-hTERT cells can create hair follicle-like structures.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

A defective gene causes hair loss and taste insensitivity in BTBR mice.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Tislelizumab can cause cutaneous lupus erythematosus.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

The new hair transplant device reduces damage to hair follicles and makes surgery more comfortable for the surgeon.

Tsc2-deficient stem cells can help understand and treat TSC-related tumors.

The conclusion is that hair transplant surgery should use microscopically dissected natural hair groupings and some new terms were suggested for clarity.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.